rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Nicholas Glover

Director

Company insider

Files Form 4 as: Director, Lite Strategy; CEO and President, Sierra Oncology.

Every Form 4 they filed

In numbers

Trades disclosed
26
Buys
2
Sells
1
Bought
$13K
Sold
$50K
Companies
2
Companies where not an officer
1
First trade
7 Jun 2013
Last trade
22 Oct 2026
Last filed
26 Oct 2026

Companies traded

Where they are an officer
Sierra OncologyDirector, Officer · last 25 Feb 20200 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
LITS Lite StrategyDirector · Biotechnology · last 22 Oct 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
22 Oct 2026filed 26 Oct 2026LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
14 Nov 2025filed 19 Nov 2025LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—55,000filing
23 Jul 2025filed 26 Oct 2026LITS Lite StrategyBiotechnologySEC FORM 4 Bought$6,0001,000 at $6.00filing
22 Jul 2025filed 26 Oct 2026LITS Lite StrategyBiotechnologySEC FORM 4 Bought$6,5501,000 at $6.55filing
15 Jul 2025filed 17 Jul 2025LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
29 Sep 2023filed 12 Oct 2023LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
5 Jul 2022filed 7 Jul 2022LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—87,500 at $0.00filing
1 Jul 2021filed 6 Jul 2021LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jul 2020filed 7 Jul 2020LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
25 Feb 2020filed 27 Feb 2020Sierra Oncologyoption or derivativeSEC FORM 4 Code A—359,158 at $0.00filing
1 Jul 2019filed 3 Jul 2019LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
4 Mar 2019filed 5 Mar 2019Sierra Oncologyoption or derivativeSEC FORM 4 Code A—607,500 at $0.00filing
12 Jul 2018filed 16 Jul 2018LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
6 Mar 2018filed 7 Mar 2018Sierra Oncologyoption or derivativeSEC FORM 4 Code A—562,780 at $0.00filing
6 Jul 2017filed 10 Jul 2017LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
6 Mar 2017filed 8 Mar 2017Sierra Oncologyoption or derivativeSEC FORM 4 Code A—195,000 at $0.00filing
30 Sep 2016filed 4 Oct 2016ProNAi Therapeuticsoption or derivativeSEC FORM 4 Code A—500,000 at $0.00filing
29 Jul 2016filed 1 Aug 2016LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
8 Mar 2016filed 10 Mar 2016ProNAi Therapeuticsoption or derivativeSEC FORM 4 Code A—161,250 at $0.00filing
15 Jan 2016filed 19 Jan 2016ProNAi TherapeuticsSEC FORM 4 Code M$4,8505,000 at $0.97filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.